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Abstract 
Background 
Cerebral palsy (CP) is a disorder of movement and posture resulting from disturbances in the 
immature brain. Accompanying impairments including secondary musculoskeletal problems 
and mental health problems are common, and impairment is life-long. Thus, from a health 
care perspective, CP is an excellent model disease for asking what frames of reference should 
guide our understanding and evidence gathering about patient well-being, and what 
instruments should we use to assess these outcomes.  
  
Objectives 
The overall aim of the study was to explore how recurrent musculoskeletal pain relates to mental 
health problems, Health Related Quality of Life (HRQL) and participation in children with CP.  
 
Methods 
In study A, children with CP 8-18 years old were recruited from the South-West of 
Norway (n=75) and from the gait laboratory at Oslo University Hospital (n=78). All 
levels of motor impairment were represented. Clinical assessment, interview (child 
and parents together), and completion of questionnaires (child and parents 
separately) were performed. The interviewer asked for any kind of recurrent pain. If 
present, pain characteristics were explored and followed by professional judgement 
whether recurrent pain probably was of musculoskeletal origin and related to CP 
(RMP). Characteristics of RMP were regarded as localisation to muscles and/or 
joints, occurrence during or after exercise and dull or aching quality. Mental health 
problems, HRQL and participation were assessed by questionnaires (Strengths and 
Difficulties Questionnaire, Pediatric Quality of Life Inventory and Assessment of 
Life Habits respectively, in addition to General Health Questionnaire for parental 
mental health). In study B, children with CP 8-18 years (n=38) that started 
continuous intrathecal baclofen therapy (CITB) at Oslo University Hospital were 
assessed the day before implantation of a pump for baclofen delivery and after 6 and 
18 months of treatment. Assessment consisted of clinical workup and parental 
interview. In cases of pain (33 children), this was assessed to be RMP before the 
child was accepted for CITB. Outcomes and explanatory variables throughout the 
study are discussed in relation to the ICF (International Classification of Function) 
that is WHO’s framework for measuring health and disability.  
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Results 
In study A, 95 children (62 %) experienced RMP. Age above 14 years was the only 
significant predictor (OR 2.7). Children reported pain severity to be moderate. Parents 
reported pain to be more severe and with higher impact on sleep than their children did. 
Children and parents reported similar impact of pain on general activity and walking. 
 
Eighty-three pairs of children and mothers reported mental health problems and 
HRQL. Mothers in addition reported their own mental health. Self-reported mental 
health and HRQL were both better than proxy-reported. RMP was associated with 
more mental health problems and reduced HRQL in self-reports, but not in proxy-
reports. Mothers reported that more own mental problems were associated with more 
child mental problems and reduced child HRQL. Correlation (ICC) between mental 
health problems and psychosocial HRQL was 0.90 for both child and maternal 
report. 
 
One hundred and five parents reported child participation. RMP and more mental health 
problems were both associated with reduced participation. More parental mental health 
problems were associated with reduced parental satisfaction with the child’s accomplishment 
of daily activities.  
 
In study B, 35 children continued CITB for 18 months. Reduced pain and improved sleep 
occurred within 6 months of treatment.  Social participation improved within 6 months and 
continued to improve until 18 months.  
 
Conclusions 
RMP is the main pain problem in paediatric CP. Systematic assessment of HRQL is suggested 
as a tool to broaden the scope of the consultation in (re)habilitation towards both pain and 
psychosocial issues. The child’s own perspectives on pain, mental health and HRQL should 
be recorded when possible in addition to that of the parents. The ICF concept of participation 
needs to be further clarified and operationalised; still the ICF reference frame is useful in both 
clinical work and research because of its comprehensiveness including the bio-psycho-social 
model and its non-categorical approach to health.  Studies of children’s narratives on pain 
experiences and studies on self-reported mental health in CP are warranted.  
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1. Introduction 
 Cerebral palsy (CP) describes “a group of permanent disorders of the development of 
movement and posture, causing activity limitations that are attributed to non-progressive 
disturbances in the developing foetal or infant brain. The motor disorders of CP are often 
accompanied by disturbances of sensation, cognition, communication, perception, and 
behaviour, in addition to epilepsy and secondary musculoskeletal problems”(1). This 
definition of CP was launched in 2006 by an international expert group. The definition is 
obviously not in accordance with the traditional biomedical model where disease is 
conceptualised in a single cause, single effect model. As CP has no cure and life expectancy 
approaches normality in our society (2), the overall perspective is that a person with CP will 
have to cope with a lifelong impairment. CP is also relatively common with an estimated 
prevalence of about 2.1 per 1000 live births in developed countries (3-8). From a health care 
perspective, this makes CP an excellent model disease for asking what frames of reference 
should guide our understanding and evidence gathering about patient well-being, and what 
instruments should we use to assess these outcomes. 
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2. Background 
2.1 The biopsychosocial approach to health  
In his classical work from 1977, George Engel challenged the biomedical model of disease 
because “it leaves no room within its framework for the social, psychological, and 
behavioural dimensions of illness.” A biopsychosocial model was proposed that provides “a 
blueprint for research, a framework for teaching, and a design for action in the real world of 
health care” (9). He argued that medicine historically has strong humanistic roots, and that 
biomedicine has categorically excluded the subjective reports of the patients (10). Further, 
Engel advocated vigorously that subjective data need not violate the conventional requirement 
for scientific respectability. Referring to system theory, he presented the biopsychosocial 
model as a scientific model constructed to take into account the missing dimensions of the 
biomechanical model (9-11). Ancient Rufus of Ephesus was credited the first document solely 
about the values of the information patients can provide:  
 
“It is important to ask questions of patients because with the help of these questions 
one will know more exactly some of the things that concern disease, and one will treat 
the disease better.” 
Rufus of Ephesus, 1000 A.D. 
(Sigerist, 1951, pp.326-327) 
 
The biopsychosocial model is incorporated in the World Health Organisation’s (WHO’s) 
International Classification of Functioning, Disability and Health, known more commonly as 
ICF (12). The ICF is WHO’s framework for measuring health and disability at both individual 
and population levels and it shifts the focus from cause to impact of disease. A key concept is 
participation, defined as a person’s involvement in life situations. In contrast, the WHO’s 
International Statistical Classification of Diseases and Related Health Problems 10th Revision 
(ICD-10) (13), gives users an etiological framework for the classification of diseases. The ICF 
and the ICD-10 are complementary both in this respect and because the ICF offers a 
dimensional approach to health contrary to the ICD-10 which approach to disease is the 
categorical. While the ICF is used on the initiative of researchers and clinicians working in the 
fields of (re)habilitation and developmental medicine, the ICD-10 is the common metric used 
in Norwegian hospitals by prescription from the Norwegian health authorities. The ICF and its 
relations to the ICD-10 are further discussed in paragraph 2.2.4. 
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Returning to the definition of CP from 2006 (1); bringing in activity limitation extends the 
approach to health from the biopsychosocial into the newer ICF concept. According to the 
authors of the definition, the ICF recognises the importance of Quality of Life (QoL), 
including the persons’ views of their own participation (14). The concept of QoL makes 
explicit the relevance of whose perspective is considered – the person with CP himself or a 
proxy (e.g. parent, teacher or health care provider) – which represents a clarification of 
important aspects of the biopsychosocial health approach.  
 
2.2 Cerebral palsy 
2.2.1 Definition and diagnosis  
A diagnosis identifies explicitly which cases are to be recorded under that term, and by 
implication, which are to be excluded. A diagnosis might also serve as the basis for planning 
treatment and for counting cases in a population. A pioneer in orthopaedic surgery, Sir 
William John Little (1810-1894), was the first to describe CP (15). In 1957, devoted clinicians 
started the “Little Club” in England which moved the concepts and descriptions of CP 
forward (16). In 1964, a new annotated definition was suggested, which may be recognised as 
the marker of the modern era of CP. According to this definition, CP is a disorder of 
movement and posture due to a defect or lesion of the immature brain (17); i.e. the concept of 
CP is shifted from an orthopaedic condition to a prototype of a developmental disability. The 
definition from 1964 remained more or less unchanged for several decades (18), which is 
remarkable in light of the concurrent progress achieved in both imaging techniques that shed 
new light on the underlying brain injury and studies on the neurobiology of and pathology 
associated with brain development that further explored aetiological mechanisms. At last, in 
2004, an international consensus group was settled to explore relevant new information. A 
proposed new definition of CP from the group was published in 2005 (19), followed by the 
final version  cited in the introduction (1).  
 
A main intention with the refined definition and classification was to give more prominence to 
the non-motor neuro-developmental disabilities that commonly accompany CP and to the 
progression of musculoskeletal difficulties that often occurs with advancing age (1). Still, 
abnormal motor behaviour (reflecting abnormal motor control) is the core feature, and the 
definition also clarifies that disorders of movement and posture that are not associated with 
activity limitations are not considered part of the CP group. CP is linked to the ICD-10 (13) 
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through the coding as a condition with a separate number within the chapter on diseases of the 
nervous system (Chapter VI, G 80) and to the ICF (12) through the emphasis of activity 
limitation.  
 
A diagnosis of CP is based on history and a thorough physical examination. In accordance 
with the definition, the most common presenting feature is delay in obtaining motor 
milestones. The history should therefore comprise attainment of developmental milestones 
and in addition gestation and perinatal events (20;21). No single physical sign is diagnostic of 
CP, whereas clusters of indicators or evolving abnormal motor patterns may be indicative. 
The major physical signs that together may lead to a diagnosis of CP are abnormal muscle 
tone, persistence of primitive reflexes, and abnormal postural reactions (22). Once abnormal 
motor behaviour is recognised, it should be verified that it is neither progressive nor resolving 
before a diagnosis of CP is made. A minimum age at which a child can reliably be considered 
to have CP is not established (23) and the diagnosis can often be made during the first 12-18 
months, except for the mildest forms. Although neuroimaging, and especially magnetic 
resonance imaging (MRI), is helpful in establishing aetiology and prognosis, no single 
imaging pattern or groups of patterns fully encompass the diagnostic findings associated with 
CP (24). For the 9% to 16% of children with CP who have normal brain imaging, further 
testing for metabolic and/or genetic conditions has been recommended. Still, in a recent study 
of  a large cohort of children with CP and normal MRIs, comprehensive metabolic testing 
failed to clarify the aetiology of CP further, even in children with atypical features (25). In the 
end, CP is a diagnosis of exclusion, and measures not to overlook a metabolic or 
neurodegenerative disease should be considered on an individual base. Another consequence 
of CP being diagnosis of exclusion, is that European CP registers does not accept children 
definitely until the age of 5 years (26).  
 
2.2.2. Classification  
Classification within a diagnosis categorises cases with similar characteristics together and 
distinguishes cases with diverse features apart. The design of a classification system will vary 
depending on the concept being classified and the intended purpose for which classification is 
being made (1). The challenges in classifying CP are expressed very to the point in a paper on 
the natural history from 1988: “Classification of cerebral palsies is difficult and important. It 
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is, of course, evident that ordinary medical criteria are almost impossible to apply. There is 
no single cause; there is no characteristic course; and in a very real sense there is no 
morbidity and mortality. Above all, the accurate description of the motor patterns may not 
give any insight into other important elements, such as intellectual and emotional difficulties” 
(27).  
 
Throughout the 1960s and 1970s, the main perspective on the classification of CP was the 
clinician’s, while in the 1980s rapidly changing neonatal care gave rise to a desire to monitor 
the prevalence and subtypes of CP as a public health marker of perinatal and neonatal health 
care. Developed countries followed Sweden (28), where surveillance of CP started as early as 
1954 (7;29-34). In 1998, 14 population based registers in eight European countries established 
the network Surveillance of CP in Europe (SCPE), founded by the European Commission. 
The aim was to develop a common database of children with CP to monitor trends, gather 
information necessary for service planning, and provide framework for collaborative research 
(35). The SCPE network has proposed a simplified classification of CP type and offers both 
an algorithm for diagnosis, a classification tree and a reference and training manual in order to 
implement a uniform way of classifying CP subtypes within the participating centres (35). In 
Norway, a national register was established in 2006 (Cerebral Parese Registeret i Norge, 
CPRN) as a part of the SCPE collaborative network. The register and its national 
collaborators promote the SCPE classifications to health care providers and health authorities. 
 
The consensus group that launched the 2006 definition of CP discusses the challenges of 
classification and refers to the SCPE classifications in its report. From the paediatric 
perspective, it is concluded that a classification of CP should include CP type, the functional 
effect of the motor impairment across trunk and limbs, accompanying impairments and the 
child’s Quality of Life (QoL) and participation (1). Each of these elements is discussed within 
separate paragraphs in the following.   
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2.2.2.1  CP type 
According to the SCPE, CP type should be classified by means of topography of the 
disturbance of movement and posture (unilateral or bilateral distribution) and which motor 
disorder is the dominating (spasticity, dyskinesia or ataxia) in terms of having the greatest 
influence on the activity limitation (35). The consensus group support that cases continue to 
be classified by the dominant type of tone or motor abnormality (1). In contrast, in the ICD-
10, the classification of CP type is based partly on which type of motor disorder is present, 
and partly which limbs are affected. The ICD-10 also allows for a diagnosis of both “mixed 
type” and “unspecified” CP contrary to the SCPE classification.   
 
2.2.2.2  Functional effect of the motor impairment 
The consensus group states that the functional involvement of the upper and lower extremities 
should be separately classified using objective functional scales (1). For the key function of 
ambulation, the Gross Motor Function Classification System (GMFCS) has been widely 
accepted and the validity and reliability is systematically tested (36-39). The GMFCS was 
developed in response to the need for a standardised system for classifying the severity of 
movement disability among children with CP (36). The underlying construct is self-initiated 
functional abilities in sitting and walking and the need for assistive devices, such as walkers 
or wheelchairs. The Manual Ability Classification System (MACS) provides a method 
analogous to the GMFCS for classifying the ability of children with CP to handle objects (40).  
As bulbar and oromotor difficulties can produce important activity limitations on the field of 
communication, the Communication Function Classification System (CFCS) is developed  
within the same concept as a method to record communication ability (41). Table 1 gives 
estimates of the distribution of CP types and ambulatory function from European studies 
covering similar birth cohorts as the present study.  
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Table 1. Distribution of CP type and ambulatory function in three 
European population based studies  (5;42-44) 
Area Norway West Sweden SPARCLE* 
Number of participants 374 167 818 
Birth year 1996-1998 1990-1993 1991-1997 
CP type (%)    
Unilateral spastic 33 30 34 
Bilateral spastic 49 45 52 
Dyskinetic 6 14 11 
Ataxic 5 11 4 
Unclassified 7 - 0 
Gross motor function (%)    
GMFCS I** 55 59 31 
GMFCS II 20 
GMFCS III 17 14 17 
GMFCS IV-V 28 27 32 
*SPARCLE = The Study of Participation of Children with CP living in Europe 
** Gross Motor Classification System 
 
2.2.2.3  Accompanying impairments  
Accompanying impairments may be caused by the same disturbances as those that caused CP, 
and/or represent indirect consequences of the motor impairment and/or be caused by 
independent factors (hence the term ‘accompanied by’ as opposed to ‘associated with’) (1). In 
general, the proportion of children with accompanying impairments increase with increasing 
GMFCS levels (45). The consensus group states that accompanying impairments should be 
classified as present or absent, and if present, the extent to which they interfere with the 
individuals’ ability to function or participate in desired activities should be described. In 
concurrence with the SCPE recommendations, the consensus group recommends that the 
presence or absence of epilepsy should be recorded, and IQ, hearing and vision should be 
assessed (1).The American Academy of Neurology has recommended screening of children 
with CP for intellectual impairment, visual and hearing impairments, as well as speech and 
language disorders (20).   
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Disturbances of sensation 
”Disturbances of sensation” reflects that vision, hearing, and other sensory modalities may be 
affected. In a population based study comprising all CP types, severe visual impairment 
(defined as functional blindness or an acuity after correction of refraction errors of no more 
than 0.3 (20/60) in the better eye) was present in 19% (45).  About 7-9 % of children with 
spastic CP have severe visual function disorders, defined as retroschiasmatic and visual 
recognition disorders. These disorders frequently referred to as cortical or cerebral visual 
impairment (CVI), comprise reduced visual acuity, visual field deficits, and difficulties in 
visual recognition. Oculomotor disorders and strabismus is also common and adds to the 
visual impairment.  About 50% of children with CP have milder visual defects (46;47). In 
general, the likelihood of severe visual impairment increase with increasing motor impairment 
(44;45;48;49).  
 
In population based studies, severe hearing impairment is reported in 2% of children with CP 
when defined as need for hearing aid or no hearing (45) and in 13% when defined as a 70dB 
or greater hearing loss (bilateral) in an audiometric testing (49). A literature review reveiled 
considerable variation in the definitions and proportions of hearing loss (range 4–13%) and 
severe hearing loss (range 2–12%) reported by CP registries in developed countries. In a 
recent Australian popultion based study, 7% of individuals with CP had bilateral hearing loss 
of a moderate to profound degree, whereas the subgroup with a severe–profound degree of 
hearing loss constituted 3% to 4% of the CP population. The degree of hearing loss was 
described as moderate/moderately severe if the hearing loss was 41 to 70dB, severe if the 
hearing loss was 71 to 90dB, and profound if the hearing loss was assessed as >90dB (50). 
Both dyskinetic type of CP and GMFCS IV-V increases the  likelihood of severe hearing 
impairment (49;50).  
 
Impaired stereognosia may increase activity limitation in the task of handling objects, and 
impaired stereognostic sense was present on the affected side in as much as 44% of children 
with unilateral CP in a Swedish population-based study (51).  
 
Standardised instruments are available to measure vision and hearing, and categories 
describing specific levels of dysfunction (e.g. visual impairment, profound hearing loss) have 
come to be generally accepted  (1).  
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Disturbances of cognition 
Population-based studies have reported intellectual disability (IQ<70) in 31 to 65 % of 
children with CP (5;28;29;52-54) and according to SCPE data, the estimated prevalence of 
severe intellectual disability (IQ50) in children 5 years old with CP is 30% (26). 
Standardised instruments are available to measure IQ, and categories describing specific 
levels of dysfunction (e.g. mild mental retardation) are generally accepted (1). 
  
Disturbances of communication 
Communication problems may arise from motor, intellectual and/or sensory processing 
deficits (55). Population-based studies indicate that about 20% of children with CP are unable 
to produce intelligible speech while up to 50% have some form of communication disorder 
(4;56-59). Dysarthria is the most common form of communication disorder (59). Generally, 
language assessment in children with severe CP is challenging, and frequently there is 
uncertainty as to whether test failures are due to physical disability or limited intellectual and 
verbal comprehension abilities (60). Whatever the cause of limitation/participation restriction, 
communication performance may be assessed with the Communication Function 
Classification System (CFCS) (41).  
 
Disturbances of perception 
Though described as common in CP, I am not aware of reports where complete cohorts of 
children with CP have been screened for specific perceptual impairments. In the literature, the 
potential contribution of a perceptual impairment is often not clarified, which is also reflected 
in the above paragraphs on disturbances of sensation and communication. Visual perceptual 
impairment and its association to spastic CP and premature birth are probably the most 
described (46;47). Recognition of perceptual impairment may require a neuropsychological 
assessment in addition to a medical and educational work-up.  
 
Disturbances of mental health 
In general, children with disabilities, and especially those with chronic neurological disorders, 
are at higher risk of experiencing mental health problems compared to their non-disabled 
peers. Externalising problems with behavioural disorders and ADHD (Attention Deficit 
Hyperactivity Disorder) seem to have the strongest association to neurological disorders, but 
also emotional problems are more common than in the general population (61). Further, there  
is a certain association between intellectual disability and mental health problems (61) as 
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demonstrated in a Norwegian epidemiological survey where the prevalence of psychiatric 
diagnoses according to the ICD-10 in children with mental retardation (IQ<70) was estimated 
to 37% and hyperkinesia was the most common disorder (62). Parental stress is found to be a 
predictor of child emotional and behavioural difficulties both in the general population (63) 
and in CP  (64;65), giving a reminder that social environmental factors have the potential to 
contribute to the aetiology of mental health problems.  
 
In CP, the population prevalence of significant emotional and behavioural problems in children 
8-12 years old has been estimated to 26 %, with severe pain being a major predictor (66). Other 
studies have shown that levels of behavioural problems are elevated in preschool children (67) 
and in school age (68) but tend to diminish during adolescence (65). A Swedish study concludes 
that mental health problems are common in children with CP, and even more common when 
epilepsy is present (69). However, these studies all rely on proxy-reports. An epidemiological 
survey of children with hemiplegia found that psychiatric disorders as judged by individual 
diagnostic assessment affected 61% of subjects. In this study, intelligence quotient (IQ) was the 
strongest consistent predictor of psychiatric problems (70).  
 
The diagnosis of a psychiatric disorder usually relies on the integration of results from 
observations, semistructured interviews and completion of questionnaires (self- and proxy- 
reports from different sources such as parents and teachers).  
 
Epilepsy 
Virtually every seizure type and many epileptic syndromes may be observed in persons with 
CP (1). The estimated overall prevalence of epilepsy in children with CP is 25-45% compared 
to 0.3-0.6 % in the general population (71;72). In a population-based study of Swedish 
children born 1987 to 1994, all children with tetraplegic CP and about one-third of the 
children with other CP types developed epilepsy. Children with tetraplegic CP tended to have 
an earlier onset of epilepsy than children with other CP types and partial seizures were the 
most common seizure type. Further, children with cognitive impairment had a higher 
frequency of epilepsy than those without cognitive impairment (73). The consensus group 
tells epilepsy to be recorded as the presence or absence of two or more afebrile, non-neonatal 
seizures, thereby following the recommendations from SCPE (1).  
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Secondary musculoskeletal problems 
People with CP may develop a variety of musculoskeletal problems, such as muscle/tendon 
contractures, bony torsion, hip displacement and scoliosis (1). Pain is a symptom often 
accompanying musculoskeletal problems (1) and is discussed separately in the below 
paragraph.    
 
Pain 
From a health care perspective, recognition of pain is important because untreated or under- 
treated nociceptive pain in childhood may predispose to persisting pain in adulthood through 
conditioning (74) or through generation of neuropathic pain, as stimulation of nociceptors 
may result in changes in the nervous system leading to chronic pain states (75). The 
International Association for the Study of Pain (IASP) defines pain as ”an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage” (76).  
 
Pain is common in children with CP (74;77) and the prevalence increases with age (74).  
Children with pain have reported that pain interfered with self-care, sleep (78) and with QoL 
(79) and parents have reported that children with pain participated less than other children 
with CP (80). However, in these studies the origin of pain or the pain’s relation to CP was not 
evaluated.  
 
Clinical assessment of pain includes assessment of intensity, frequency, quality, location and 
temporality. The term severity should be avoided if possible, holding elements of both 
intensity and frequency. Measurement tools adapted to child age are developed; most of them 
are in the paper-based questionnaire format, in which a standardised questionnaire is to be 
filled in. Diaries represent another option. Interview can replace written self-report if motor or 
visual impairment limits reading or writing. Pain intensity may be reported on a visual 
analogue scale (VAS) or a numeric rating scale (NRS). If the purpose is comparison across 
study populations, one has to be aware that children tend to rate significantly more pain when 
using a smiling face to denote “no pain” than if a neutral “no pain” face is used (81). Pain may 
also be regarded as an observable measure, and standardised methods for the observation of 
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pain behaviour is developed that makes it possible to obtain information from the non-verbal 
person (82).     
 
2.2.3 Quality of Life and Health Related Quality of Life  
Quality of life (QoL) is defined by the WHO as “individuals’ perceptions of their position in 
life in the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards and concerns”(83). It is a broad ranging concept incorporating 
in a complex way the persons’ physical health, psychological state, level of independence, 
social relationships, personal beliefs and their relationships to salient features of the 
environment. The concept of QoL may also be regarded as a continuum of issues from 
existentiality to single symptoms (e.g. pain). The “gap theory” pinpoints the gap between 
expectations and experience as the essence of QoL. According to this, QoL is described as an 
inverse relationship to the difference between an individual’s expectations and his perception 
of a given situation. That means “the smaller the gap, the better the quality of life”(84).  
 
Quality of life (QoL) research started in sociology and has been adopted in medicine. In the 
early literature, there was a great overlap with terms such as handicap, function and activities 
of daily living. Present literature is clearer, and the subjective, self-reported element is now 
common to all definitions and instruments in use. Most instruments identify a number of 
crucial dimensions e.g. the perception of emotional, social, material and physical well-being, 
self-esteem and self-determination. QoL is individual, and QoL assessment thereby highlights 
the fact that an apparently similar medical condition or even similar levels of functioning can 
be perceived by individuals in many different ways (14).  
 
It is a challenge for researchers and clinicians to capture this subjective aspect in CP, since 
the patient may be a small child or intellectually or visually impaired. The tradition is to 
rely on proxy-report when self-report is impossible to obtain.  Although much has been 
written about the relationship between child and proxy ratings in QoL/HRQL research, the 
impact of child and parent characteristics on agreement between children and parents has 
not been consistently considered within studies (85). However, there are trends; parents of 
children in a non-clinical sample tend to report better child HRQL than children 
themselves, while parents of children with health conditions tend to underestimate child 
HRQL (85). Further, parental well-being is found to influence parents' perception of their 
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child's QoL (65;86) emphasising that in a family perspective,  parent proxy-report adds 
valuable information.  
 
The slogan taught in paediatrics for generations that “children are not small adults” is 
reflected in the relatively new sociology of childhood where status is given to the lives of 
children and adolescents “here and now” rather than valuing childhood simply as a 
transitional phase to adulthood. In accordance with this view, modern QoL instruments are 
generated de novo from what young people say, rather than being modified adult instruments 
or instruments with items that professionals think are relevant to children and young people 
(87). Over the years, a lot of instruments are developed (88) – to an extent that a “mania” for 
measurement of QoL has been addressed (89). 
 
Paediatric quality of life work has developed primarily from concerns about the impact of 
aggressive treatment on children especially in the early days of cancer treatments, as well as 
for premature children undergoing high-tech treatment (90). As a consequence of this shift in 
focus from survival to life quality (both in paediatrics and in adult medicine), Health Related 
Quality of Life (HRQL) has emerged as an outcome measure of health care (85). HRQL is 
usually considered a subgroup of QoL consisting at the minimum of physical, psychological 
and social health dimensions as described by WHO (91). One definition of HRQL is “an 
individual’s perception of various aspects of their lives that they think is affected by a 
particular medical condition and its treatment ”(92). This HRQL concept is readily understood 
if an aspect of life is considered that is unique to this particular medical condition, but if the 
aspect considered is experienced by all children, the concept of HRQL is more difficult to 
grasp. In other words, if HRQL is about aspects of QoL which are particular to children with a 
specific condition, then it cannot apply to all children (92).  
 
In paediatric CP, the Study of Participation of Children with Cerebral Palsy Living in Europe 
(SPARCLE-I study) (42) has provided substantial insight into the health and QoL of children 
8-12 years old. In the SPARCLE-study, children self-reported QoL comparable to non-
disabled peers, but pain was associated with reduced QoL in all domains (79) and self-
reported severe child pain was the main factor explaining parents’ ratings of their child’s QoL 
better than the children themselves (93). In children with intellectual disability (IQ<70) 
parents reported better child QoL than professionals (teachers, therapists, residential carers) 
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on the psychological domain and reduced QoL on the social support domain. Further, high 
level of stress in parenting was associated with parents reporting reduced child QoL compared 
to professionals, while child pain was associated with professionals reporting reduced child 
QoL compared to parents (94). Parents also reported that gross motor function level correlated 
with health from the physical well-being perspective, but not with the psychological and 
emotional aspects of health (95). Although mental health is thought to be close to 
psychosocial well-being, I am not aware of studies on mental health and QoL in CP. More 
important, self-reported mental health was not included in the SPARCLE-study and I have not 
been able to find any studies on this topic in CP.    
 
Proceeding to adolescents, a literature review from 2007 on QoL among adolescents with CP 
summarised findings into important trends: 1) Individuals with CP have decreased QoL and 
HRQL compared with a normative population in some, but not all areas of well-being,  
2) Functional status measures such as the GMFCS are reliable indicators of variations in 
physical function, but do not correlate consistently with psychosocial well-being and  
3) Although adolescents with CP have different life issues than adults or children, limited 
research on factors associated with QoL and HRQL has been performed in this age group 
(96). The SPARCLE - II study (97) collecting data from the same children four years after 
SPARCLE-I is expected to provide new insights into QoL and health status in adolescents 
with CP.  
 
A good measure of QoL/HRQL is regarded to at least offer both self-report  and proxy 
versions to allow for parent completion, be brief, age-appropriate and have documented 
reliability and validity (90). For HRQL assessment, measurement tools may be generic or 
disease-specific. Disease-specific measures are designed to assess symptoms and functions 
associated with a particular disease and treatment effects (98). A compromise between a 
generic and a disease-specific measure is the development of measures holding a generic core 
set of items with disease-specific add-ons or modules. Current advise is not to measure 
QoL/HRQL for its own sake, but to choose the appropriate measurement tool in order to 
answer a specific question (88;92). Self-report and proxy-report provides different 
information and both should be obtained when possible also because it is the parent’s 
perception of their child’s HRQL that is the principal determinator of utilisation of paediatric 
health care services (99).  
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2.2.4 Participation and the International Classification of Functioning, Disability and 
Health (ICF)  
The ICF was officially endorsed by all WHO Member States in May 2001 and describes 
health through the lens of functioning. It assesses interactions among body functions 
(including psychological function) and body structures (referring to anatomy), activities (tasks 
and demands of life), and participation (engagement in life situations).The WHO website 
tells:” Health and health-related domains are classified from body, individual and societal 
perspectives by means of two lists: a list of body functions and structure, and a list of domains 
of activity and participation. Since an individual’s functioning and disability occurs in a 
context, the ICF also includes a list of environmental factors”(12). Figure1 illustrates the 
conceptual components of the ICF and their relations. Health condition (disorder or disease) 
refers to the ICD-10 taxonomy:  
 
Figure 1. ICF 
 
 
The diagram identifies the three levels of human functioning classified by ICF: functioning at 
the level of body or body part, the whole person, and the whole person in a social context.         
Corresponding to this, disability involves dysfunctioning at one or more of these levels: 
impairments, activity limitations and participation restrictions. Further, impairments are 
defined as problems in body function or structure, such as organs, limbs and their 
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components. Activity limitations are defined as difficulties an individual may have in 
executing activities, and participation restrictions are problems an individual may experience 
in life situations. At last, the environmental factors make up the physical, social and 
attitudinal environment in which people live and conduct their lives (12). 
 
The list of domains in ICF becomes a classification when qualifiers are used. Qualifiers 
record the presence and severity of a problem in functioning at the body, person and societal 
levels. For the classifications of body function and structure, the primary qualifier indicates 
the presence of impairment and, on a five point scale, the degree of the impairment of 
function or structure (no impairment, mild, moderate, severe and complete). In the case of the 
Activity and Participation list of domains, two qualifiers are provided that make the ICF 
helpful in describing what a person with a health condition can do in a standard environment 
(their level of capacity), as well as what they actually do in their usual environment (their 
level of performance). The Performance qualifier measures the difficulty the respondent 
experiences in doing things, assuming that they want to do them. In contrast, the Capacity 
qualifier focuses on limitations that are inherent or intrinsic features of the person themselves. 
These limitations should be direct manifestations of the respondent's health state, without the 
assistance. The level of capacity should be judged relative to that normally expected of the 
person, or the person's capacity before they acquired their health condition (12).   
 
The International Classification of Functioning, Disability and Health for Children and Youth 
(ICF–CY) (12) was launched in 2007 as the rapid growth and changes that occur in the first 
two decades of life were not sufficiently captured in the ICF. The ICF-CY allows coding of 
learning and child-specific environmental factors. In addition, it permits developmental 
aspects of functioning to be coded, such as learning through actions and playing and acquiring 
language. The ICF-CY adds the term and the concept of ‘developmental delay’ to the 
universal severity scale included in the ICF. This enables the documentation of lags in the 
emergence of structures, functions, capacity, performance of activities and participation in 
children and youth, and recognises that severity of the observed delay(s) may change over 
time. A recent study describes the clinical application of ICF-CY in the neurorehabilitation of 
a 12 year old child with dyskinetic CP (100). The ICF-CY is also regarded to provide an 
excellent framework in comparing the content of HRQL measures for children and youth with 
CP (101). Both the ICF and the ICF-CY are translated into Norwegian.  
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In paediatric CP,  a recent study considering treatment outcomes supports that participation is 
regarded a domain of importance both by parents, medical professionals and the youths 
themselves (102). Adolescents in another study identified issues related to active leisure, 
mobility, school and socialisation as important areas for improvement of participation (103). 
In the SPARCLE - I study (42), parents reported that children CP 8-12 years old with CP 
participated less frequently in many, but not all areas of everyday life, compared with children 
in the general population (104) and that children with pain had even lower participation (80). 
Mental health problems were not included in the assessment of participation, and as earlier 
mentioned, the origin of pain was not evaluated. 
 
Participation may be assessed by observation, questionnaires or semistructured interviews.  
Aspects such as difficulties with the accomplishment of daily activities and social roles (105), 
satisfaction (105), independence, enjoyment, diversity (106) and frequency (104) or intensity 
(107) may be incorporated. Assessment tools are said to vary widely in their 
operationalisation of participation, measure participation only to a limited extent, and refer to 
both objective and subjective aspects in the assessment (108;109). Further, a consensus on 
how to describe participation restriction in CP does not exist (110), as core sets of ICF 
categories to be included in the assessment have not been developed (in contrast to a range of 
other chronic conditions) (111). Still, the description of activity limitation/participation 
restriction relevant to the motor impairment is approaching consensus. According to the 
developers, the basic ideas concerning capacity and performance included in the original 
GMFCS concepts were sharpened considerably with the publication of the ICF, and it has 
become clearer that the major focus of the GMFCS is on motor function under ordinary 
circumstances, rather than on capacity as observed under optimal conditions and assessed 
with formal tools (112). The equivalent classification systems for manual function (MACS 
(40)) and communication  (CFCS (41)) were developed using lessons learned from the 
development of the GMFCS (112). In contrast, I am not aware of any consensus on how to 
describe activity limitation/participation restriction relevant to pain and mental health 
problems in CP.  
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3. Aims of the study 
The overall aim of the study was to explore how recurrent musculoskeletal pain related to CP 
(RMP) relates to mental health problems, HRQL and participation.  
The specific aims were: 
 
1. To explore the prevalence, predictors, severity and impact of RMP (Paper I). 
 
2. To extend previous knowledge on mental health problems with children’s own report 
and relate RMP to mental health and HRQL (Paper II). 
 
3. To relate RMP and mental health problems to participation (Paper III). 
 
4. To describe the course of participation after introduction of treatment for RMP 
     (Paper IV). 
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4 Methods         
4.1 Study design and study populations 
Two studies on RMP are included; Study A that has a cross-sectional design and Study B that 
has a prospective, longitudinal design. The main criterion of inclusion was a diagnosis of CP. 
 
Study A (paper I-III) includes two groups of participants:  
1) A population-based group covering adolescents born 1992 and 1993 living in the South-
Eastern region of Norway.  
2) A hospital-based group covering patients 8-18 years old who completed 3-dimensional 
gait analyses at Oslo University Hospital. Inclusion period was Feb.1. 2009 to Jan. 31. 
2010. 
 
In Study B (paper IV), participants are children and adolescents < 18 years who started 
continuous intrathecal baclofen therapy (CITB) at Oslo University Hospital, Rikshospitalet. 
Inclusion period was Sept.16. 2002 to Sept. 15. 2005. Observation time was 18 months. 
 
4.2 Enrolment of participants  
Study A, population-based group:  
Letters of invitation to potential participants were sent to all habilitation units within the 
specialist health care system, to all general practitioners and to the public system for special 
education in all municipalities. The region comprises both urban (e.g. Oslo), suburban and 
rural areas and covers about half of the Norwegian population (4.8 mill. in 2008). The 
Norwegian Cerebral Palsy Association in addition advocated the study to their members. The 
present study is part of a larger study of transition from childhood to adulthood, and the actual 
birth cohorts were chosen because they attended the last two years in primary school at the 
time of inclusion.  
 
Study A, hospital based group:  
Letters of invitation were sent from the hospital together with the appointment for 3-
dimensional-gait analysis. Eighty-nine per cent of potential eligible patients participated. One 
patient did not want to participate and the remaining was lost because of logistic coincidences 
in the gait laboratory. The flowchart (figure 2) outlines the study populations in paper I-III. 
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Figure 2. Study population study A. Roman numerals refer to paper. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study B: 
All children with CP who started CITB during the inclusion period were enrolled.  
38 patients participated. One patient discontinued CITB after 3 months because the family 
suspected intolerable side-effects (agitation). In two patients the infusion pump had to be 
removed because of infection and the families did not want another pump. The remaining 35 
(92 %) continued treatment throughout the observation period.  
 
4.3 Measures 
Psychometrics is the field of study concerned with the theory, technique and functioning of 
psychological measurements. The field is primarily concerned with the construction and 
validation of measurement instruments such as questionnaires, interviews and tests. Key 
concepts are reliability and validity. A reliable measure is one that measures a construct          
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consistently across time, individuals, and situations. Content validity refers to whether a 
measure appears to measure what it claims to do. Content validity is usually evaluated by the 
judgement of several experts (both real life experts and professionals) within the field of 
interest. Construct validity refers to a measure’s consistent relations to the concepts (i.e. 
constructs) that are being measured. Construct validation is therefore a continuous process 
involving the theory behind the concepts and various psychometric testing. Internal 
consistency is a measure that refers to the correlations between different items on the same 
test (or the same subscale on a larger test). It measures whether several items that propose to 
measure the same general construct produce similar scores. Internal consistency may be 
measured with Cronbach's alpha, a statistic calculated from the pairwise correlations between 
items. Further, a construct such as HRQL/QoL and participation cannot be measured directly; 
it is captured by calculating from a group of questions the value of an underlying latent 
variable. An alternative way of thinking about internal consistency, is that it is the extent to 
which the items of a test measure the same latent variable. In cases of translations, cross-
cultural studies are usually conducted to ensure that the properties of an instrument do not 
change for different cultures and settings. In the following, outcomes and explanatory 
variables are listed and comments on their psychometric properties are given where 
appropriate.   
 
4.3.1 Outcomes  
 Recurrent musculoskeletal pain is the main outcome in paper I. The 
assessment was performed stepwise. During an initial interview, children and 
parents together were asked for any kind of recurrent pain and if present, pain 
characteristics were explored. After clinical assessment performed by the 
same paediatrician and/or therapist that performed the interview, the 
professionals judged whether recurrent pain probably was of musculoskeletal 
origin and related to CP. More details are given in paper I (113). 
 
 Pain intensity and frequency (paper I, II and IV) was assessed in three ways: In paper I, 
the children recorded maximum pain intensity within the last month on the Faces Pain 
Scale-Revised (FPS-R). The FPS-R is a 0-10 scale with a neutral no pain face that has 
demonstrated a linear relationship with visual analogue pain scales in the age range 4-16 
years (114). In paper I and II, children and parents both responded to the two questions 
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on pain from the Child Health Questionnaire (CHQ) (115); “How much bodily pain or 
discomfort” and “How often is there bodily pain or discomfort” during the last month. 
CHQ is a generic instrument for assessment of health status or HRQL in children  that 
has been translated, cross-culturally adapted, and evaluated according to international 
guidelines for use in a number of countries including Norway (116), and also is validated 
for CP (117) and used in the SPARCLE study (English version)(118). The two responses 
on pain are reversely scored, and the mean is linearly transformed into a 0-100 scale 
where 100 is no pain. In paper IV, the average daily number of episodes of pain when not 
sleeping and the all over intensity of pain the last four weeks as observed by parents were 
recorded by a therapist during the assessment of the patient. Number of pain episodes 
was spelled out from 0= “none” to 4= “pain almost all the time” and pain intensity was 
spelled out from 0= “no pain” to 4 = “pain of very high intensity”.  
 
 Impact of pain (paper I and IV) was reported by children and parents in paper I and by 
parents in paper IV. In paper I, impact of pain was assessed with selected items from 
the Brief Pain Inventory (BPI), Norwegian version (119). BPI measure the level of 
pain interference with function using 0 (no interference) to 10 (complete interference) 
numerical rating scales. Three items were chosen (general activity, walking and sleep) 
and the time span changed from pain experienced during the last 24 hours to pain 
experienced the last four weeks. In paper IV, how often (on average) the child woke 
up during night the last four weeks was recorded by the interviewer on a 5 point scale 
spelled out with 0= “never or almost never” to 4= “almost all the time”. 
 
 Localisation of pain (paper I) was obtained from the body outline (anterior and 
posterior view) of the Brief Pain Inventory (BPI) (119).  
 
 Gross motor function capacity (paper IV) was assessed with the Gross Motor 
Function Measure (GMFM-66), Norwegian version. The GMFM is a criterion-
referenced observational measure that originally was developed and validated to assess 
children with CP (120). Items are scored on a four point ordinal scale (0=does not 
initiate the activity, 3=completes the activity). By the age of five years, children 
without motor delays in general are able to accomplish all items. The current version 
has demonstrated good psychometric properties (intrarater reliability ICC =0.99, 
construct validity ascertained by Rasch analyses, and good sensitivity to change) 
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(121;122). A Norwegian version is developed in which inter-rater reliability was found 
satisfactory (Pearson correlation 0.75-1.00) (123). 
 
 Spasticity of the knee flexors (paper IV) measured as degree of resistance to passive 
knee extension was rated on a Modified Ashworth Scale (124) which has 
demonstrated adequate levels of inter-rater reliability in adults (weighed kappa =0.87 
for overall agreement in lower limbs)  (125;126). The test was performed at a 
moderate speed (180°/s) by two experienced therapists.   
 
 Child mental health (paper II) was assessed with The Strength and 
Difficulties Questionnaire (SDQ) (127), Norwegian versions for self-report 
and proxy-report. The SDQ is a behavioural screening questionnaire 
consisting of 25 items. Each item has 3 response alternatives; “not true”, 
“somewhat true” or “certainly true.” The 25 items are divided between 5 
scales: Emotional Symptoms, Conduct Problems, Hyperactivity, Peer 
Problems and Prosocial Behaviour. Responses to negatively worded items are 
scored 0-1-2 and positively worded items are scored 2-1-0. The scores for all 
items on the first four scales are summed to a Total Difficulties Score (TDS), 
higher scores indicating more problems. The SDQ shows satisfactory 
reliability (mean Crohnbach  =0.87 for internal consistency and mean=0.62 
for test-retest correlation) and validity (low “contamination” between 
internalising and externalising scales, high predictability of independently 
diagnosed psychiatric disorder) (127;128). Studies on some psychometric 
properties of the Norwegian versions have been performed (129-131) and 
normative data based on a large representative Norwegian sample are 
obtained (132). In addition, a validation of the English version is undertaken 
in CP with good results except in the most impaired children for whom the 
validity of SDQ is questioned (66). In the present study, self- and maternal- 
reported TDS are given.  
 
 HRQL (paper II) was assessed with the generic Pediatric Quality of Life 
(PedsQL) 4.0 (133) that includes subscales of physical, emotional, social and 
school function. The Psychosocial Summary Scale is the sum of the latter 
three subscales. All scales are comprised of parallel child self-report and 
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parent proxy-report formats. The instructions ask how much of a problem 
each item has been during the past month (0=never a problem; 1=almost 
never a problem; 2=sometimes a problem; 3=often a problem; 4=almost 
always a problem). The wording is negative (e.g. I hurt or ache, It’s hard for 
me to run, I feel afraid or scared). Items are reversely scored and linearly 
transformed into a 0-100 scale, so that higher scores indicate better HRQL. 
Reliability and validity of the original version are tested in the general 
population and in patient populations included CP with good results (internal 
consistency showing Crohnbach  >0.80 for all child and parental scales, 
PedsQL distinguishing between healthy children and paediatric patients) 
(99;134) and the psychometric properties of the Norwegian translation are 
evaluated in the general population and found satisfactory (internal 
consistency showing Crohnbach =0.77-0.88 , factor analyses showing 
results comparable with the original version except for the Physical Health 
Scale) (135). In the present study, self- and maternal-reported Total Scores 
and Psychosocial Summary Scores are given.  
 
 Participation is the only outcome in paper III and the primary outcome in paper IV. 
Parents are the responders in both papers. In paper III, participation was assessed 
using the Assessment of Life Habits (LIFE-H) short versions; General Version 3.1 
(136) for children 14 years old and Child 5-13 Version 1.0 (105) for younger 
children – both in Norwegian translations. Both versions comprise 64 items distributed 
on 10 and 11 categories, respectively. The LIFE-H has been proven to be a reliable 
instrument in older adults (intrarater ICC>0.75 for 7 categories, inter-rater ICC 0.89 
for total score and daily activities subscore and ICC=0.64 for social roles subscore 
(136)). The child version is tested for reliability and validity in children with various 
impairments, including CP, showing moderate to excellent results (intrarater 
correlation ICC0.78 for 10 categories, content validity assessed as good by an expert 
group, content compared with 2 other measures used in child rehabilitation finding 
that the content of LIFE-H allows for a complete description of participation (105)). 
Participants are instructed that responses should reflect the young person’s usual way 
of carrying out life habits (i.e. performance). Both versions use an item score ranging 
from 0 to 9, developed by the combination of the two concepts of the scale (degree of 
difficulty and types of required assistance), where 0 indicates total impairment 
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(meaning that the activity or social role is not accomplished or achieved) and 9 
indicates optimal participation (meaning the activity or social role is performed 
without difficulty and without assistance). In order to allow for the variable number of 
items in each category, and the number of ‘non-applicable’ items for the respondent, a 
transformation of scores (on a 0–10 scale) is used to give similar weighting to each 
category of life habits. After transformation, 0 means total impairment and 10 means 
the activity or social role is performed without difficulty and without assistance. The 
measure also comprises a second scale that evaluates the individual’s level of 
satisfaction with the accomplishment of life habits. This score varies from 1 (very 
unsatisfied) to 5 (very satisfied). We adjusted the range to  -10 to +10 where 0=”more 
or less satisfied.” We calculated both accomplishment scores and satisfaction scores 
for each category, a global score for all items, and subscores for daily activities and 
social roles respectively.  
 
In paper IV, participation was assessed by interview according to the Norwegian 
version of the Pediatric Evaluation of Disability Inventory (PEDI) (137). The PEDI 
was designed to measure both capacity and performance simultaneously and 
comprehensively in the domains of self-care, mobility, and social functioning in 
children with disabilities aged 6 months to 7.5 years. PEDI offers a Functioning Skills 
Scale and a Caregiver Assistance Scale. Together 197 items corresponding to the 
domains of the activity and participation classification of the ICF measures if the 
activities can be performed or not in most situations (138). Scoring is 1 (performed) or 
0 (not performed). Age- standardised normative scores with mean (SD) of 50 (10) are 
provided. PEDI also assesses the number of assistive devices (ICF environmental 
factors).  Several studies have examined the psychometric properties of the PEDI and 
provided evidence for the PEDI as a reliable, valid and sensitive-to-change assessment 
for both normally developing and disabled children (139-141) and the Norwegian 
version is also evaluated with good results (intra- and inter-rater ICC 0.95-0.99, cross-
cultural validity of American normative data for a general Norwegian population 
satisfactory) (142-144).  Interviews were performed by trained professionals, which is 
pointed out as important (143). In paper IV, the scaled scores (0 to 100, reflecting 
increasing level of functioning in each domain) of the Functional Skills Scale and the 
Caregiver Assistance Scale are reported.  
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4.3.2 Explanatory variables 
 
 CP diagnosis and classification of CP type followed the recommendations from the 
consensus group published in 2006 (1) (paper I-IV). 
 
 Functional effect of the motor impairment was recorded as gross motor performance 
according to the GMFCS (36) (paper I-IV). The GMFCS describes the ambulation of 
children with CP in one of five ordinal levels and includes descriptions for each level 
across four age groups: less than 2 years, 2 to 4 years, 4 to 6 years, 6 to 12 years, and 
12-18 years (38).  Children in Level I perform all the activities of their age-matched 
peers, albeit with some difficulty with speed, balance, and coordination; children in 
Level V have difficulty controlling their head and trunk posture in most positions and 
achieving any voluntary control of movement. After the age of 6 years, children at 
GMFCS level I-II walk without assistive devices, children at level III walk with 
assistive device, and children at level IV obtain mobility in a wheelchair.   
 
 Socioeconomic factors (paper I-III): Questions were selected from Parental Account 
of Children’s Symptoms, Norwegian version (PACSNO)(145). We recorded whether 
the child lived together with two parents, whether the place of living was urban or 
rural, the length of mother’s education, and family economy.  
 
 Parental mental health (paper II and III) was assessed with the General Health 
Questionnaire (GHQ-30), Norwegian version. The General Health Questionnaire 
(GHQ) (146)  is designed to detect psychiatric disorders in community settings and 
nonpsychiatric clinical settings. The GHQ-30 includes 30 items covering symptoms 
considered to reflect distress and psychopathology in five dimensions corresponding to 
anxiety, feelings of incompetence, depression, difficulty in coping, and social 
dysfunction over the past 2 weeks (147). Both positive and negative questions are 
included. Possible responses to each item are “not at all, somewhat/same as usual, 
rather more than usual and much more than usual” respectively. Responses may be 
recorded as 0-1-2-3 giving a possible score of 0–90 or 0-0-1-1 giving a possible score 
of 0-30. A high score indicates more psychosocial distress. Reliability of the factor 
structure in the English version have proved excellent (148) and the Norwegian 
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translation has been used in several studies (149-152). In the current study, the 0-1-2-3 
scoring was performed. 
         
4.4 Statistics 
Continuous data were described using median with 25th-75th centiles and in addition mean 
with standard deviation (SD) when appropriate for comparison with other studies. 
Categorical data were described using proportions. Differences between independent 
groups for continuous data were quantified with the Independent-Samples T-test in cases of 
observations approximating the normal distribution and with Mann Whitney Wilcoxon test 
in cases of severe skewness of observations or few observations. For categorical data, Chi 
squared (X2) test or Fisher’s exact test for small samples was applied. Differences between 
observed means and means reported in the general population were analysed with one-
sample T-tests (paper II). Differences in mean between related samples were analysed with 
Related Samples Wilcoxon Signed Rank Test (paper I) or Paired-Samples T-test (paper II 
and IV). Differences in variances were analysed with one-way analyses of variance and 
post hoc tests for multiple comparisons was performed (Tukey) (paper I and III). 
Consistency between scores were analysed with intraclass correlation coefficients (ICC) 
assuming random effects (paper I and II). Correlations were analysed with Spearman’s 
rank correlation because of skewness of observations (paper III). Regression models were 
fitted in order to analyse potential associations between explanatory variables and selected 
outcomes. Logistic regression was applied for binary outcomes (paper I) and linear 
regression was applied for linear outcomes (paper II and III). Residual diagnostics was 
performed to explore the fit between models and observed data. Bootstrapping was 
performed to derive estimates for the confidence intervals for the odds ratios (OR) in the 
logistic regression model (paper I) and for the regression coefficients (B) (paper III). In 
paper III, model validation was performed by a bootstrapping program performing 1000 
bootstrapped repeats of backward stepwise linear regression on candidate variables. For 
each successive variable included from the bootstrapping, a resampling validation program 
was used to perform 250 replicated partitioning of the data into test subsamples. Then the 
coefficient of determination, R2, from the test sample was used to assess best fit. Collinear 
diagnostics was also applied to avoid biased estimates and overfitting because of 
collinearity. Potential interaction terms were considered in the regression analyses, but 
none was included. Missing values were taken into account by casewise deletion. We had a 
5 % statistical significance level and performed two-tailed testing. Analyses were 
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performed in PASW Statistics, release 18.03 (IBM Corporation, Armonk, New York, 
USA) (paper I-III), SPSS 16.0 version (SPSS Inc, Chicago, IL, USA) (paper IV) and 
STATA/SE, version 12.0 (StataCorp LP, College Station, TX, USA) (regression model 
paper III).  
 
4.5 Ethics 
Study A: The study protocol was approved by the National Committee for Research Ethics. 
Written informed consent to the research and publication of the results was obtained from 
parents and from participants adjusted to age and ability to give informed consent. Separate 
written information was provided for adolescents 12-16 years old. Adolescents	
old 
gave their written consent, and adolescents 12-16 years old were encouraged to give their 
written consent if they wanted to do so. If intellectual disability was present, parents judged 
whether written informed consent from the adolescent was possible to obtain. In the 
population-based group, potential participations got no more than one postal reminder if they 
did not respond to the first letter. 
 
Study B:  As no changes in hospital routines were made, consent from the local ethical 
committee was not applied for. The study was set up as quality assurance of a given medical 
treatment, and written consent from participants was therefore not obtained. At the time of 
publication, the duration of the observation time was long compared to other studies, thus 
publication of the results was regarded to be of potential general utility for families 
considering CITB. It was secured that identification of the participants is not possible.   
 
The Commissioner for the Protection of Privacy in Research at Oslo University Hospital 
approved data storage in both studies.  
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5 Summary of results 
 
Table 2 gives an overview sorted by paper of the health problems studied and their domains of 
potential impact: 
 
Table 2. Overview of health problems and their potential impact sorted by paper 
 Health problem  Domain of potential impact  
Paper I Recurrent musculoskeletal pain General activity 
Walking  
Sleep 
Paper II Recurrent musculoskeletal pain  
Mental health problems 
HRQL 
Paper III Recurrent musculoskeletal pain  
Mental health problems 
Participation 
Paper IV Recurrent musculoskeletal pain Sleep 
Gross Motor Function Capacity 
Participation 
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Paper I: “Characteristics of recurrent musculoskeletal pain in children with cerebral palsy 
8-18 years old.” 
One hundred and fifty three participants, aged 8-18 years, were assessed with clinical 
examination, interview and questionnaires. The assessment of pain was performed stepwise. 
First, children and parents together were asked for any kind of recurrent pain. If recurrent pain 
occurred, the child indicated its maximum intensity within last month on the FPS-R before 
children and parents responded separately to the two questions on pain in the CHQ and to 
questions on localisation and impact of pain. CP type distribution was unilateral spastic 38 %, 
bilateral spastic 55 %, dyskinetic 6 % and ataxic 1 %. GMFCS levels were I 35%, II 37%, III 
13%, IV 5% and V 10%. Ninety-five (62 %) children across all GMFCS levels experienced 
recurrent musculoskeletal pain related to CP (RMP) as judged by the professionals running 
the study. Age above 14 years was the only significant predictor with (OR 2.7). Children 
reported pain intensity to be moderate. Parents reported pain to be more severe and with 
higher impact on sleep than their children did. Children and parents reported similar impact of 
pain on general activity and walking. Multiple pain sites were usual and lower limbs (included 
hips) was the site of maximum pain in 70% of the children. The most common pain intensifier 
was walking or running and immobilisation. The most common pain relievers were rest and 
massage or change in position. Over-the-counter drugs alone or in combination with other 
measures had been used during the last month by 35% of the children. Three children did not 
take any measures to relieve pain.    
 
Paper II: “Mental health, health related quality of life and recurrent 
musculoskeletal pain in children with cerebral palsy 8-18 years old.” 
Eighty-three participants, median age 15.7 years, were assessed with clinical 
examination, interview and questionnaires. Gross motor function was GMFCS level I 
42%, level II 42%, level III 12% and level IV-V 5%. Children self-reported mental 
health on the SDQ, HRQL on the PedsQL, and pain on the CHQ. Mothers proxy-
reported on the same questionnaires and in addition reported their own mental health 
on the GHQ. Compared to Norwegian typically developing children, children 
reported similar TDS and lower PedsQL total scores while mothers reported higher 
TDS and even lower PedsQL total scores. ICC between SDQ total difficulties score 
and PedsQL psychosocial summary score was 0.90 for both child and maternal 
report. RMP was associated with more mental health problems and reduced HRQL in 
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self-reports, but not in proxy-reports. Mothers reported that higher own GHQ scores 
were associated with more child mental problems and reduced child HRQL.  
 
Paper III: “Parent-reported participation in children with cerebral palsy 8-18 years old: 
The contribution of recurrent musculoskeletal pain and mental health problems.” 
One hundred and five participants, median age 14 years, were assessed with clinical 
examination, interview and parental questionnaires. CP type distribution was unilateral spastic 
37 %, bilateral spastic 56 % and dyskinetic 7 %. GMFCS levels were I 33 %, II 40 %, III 15% 
and IV-V 11 %. All parents reported child participation on LIFE-H, 95 parents reported child 
mental health on the SDQ, 88 reported socio-economic status, and 88 recorded own mental 
health on the GHQ. Parents reported that child RMP was associated with reduced 
accomplishment and reduced satisfaction with the accomplishment of both daily activities and 
social roles. Higher SDQ scores were associated with reduced accomplishment of daily 
activities and social roles and with reduced satisfaction with the accomplishment of social 
roles. Parents also reported that higher GHQ scores were associated with reduced satisfaction 
with the accomplishment of daily activities. The operationalisation of participation concept in 
general is discussed in the paper.   
 
 
Paper IV: “Continuous intrathecal baclofen therapy in children with cerebral palsy; the 
timing of effects may have implications for therapy.” 
Thirty-five children who started CITB were followed for 18 months. GMFCS levels were III 
(two children), IV (13 children), and V (20 children) respectively. In cases of pain (33 
children), this was assessed to be RMP before the child was accepted for CITB. Pain, number 
of awakenings during night, spasticity, gross motor capacity and participation were recorded 
the day before implantation of a pump for intrathecal drug infusion and after 6 and 18 months 
of treatment respectively. Reduced pain intensity, reduced pain frequency and improved sleep 
occurred within 6 months of treatment. Social participation improved within 6 months and 
continued to improve until 18 months. Gross motor function also improved, but with a 
latency.  
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6 Discussion  
The present study claims that recurrent musculoskeletal pain is the main pain problem in 
children with CP, it gives self-reported mental health, and it includes both recurrent 
musculoskeletal pain and mental health in the assessment of participation. Further, a report on 
the course of pain and participation after the introduction of CITB is given. At the time of 
publication, such reports were scarce or absent. Strengths and limitations of the study are 
discussed in the following paragraphs. A discussion of how major outcomes relate to the ICD-
10 and the ICF respectively, and how all variables relate to the ICF is included.  
 
6.1 Discussion of major findings    
Referring to the introduction - what frames of reference should guide our understanding of 
patient well-being?  For a physician, the obvious answer – and the professional obligation - is 
knowledge and understanding of the medical condition; in paediatrics the developmental and 
familial perspectives included. In the present study, aetiology of CP and influence on the ICF 
level of body structure are not considered. Focus is on the accompanying features recurrent 
musculoskeletal pain and mental health problems, their potential relationship and potential 
impact on selected outcomes. The a priori assumption that pain as an unpleasant sensory and 
emotional experience (76) and mental health problems (153) are relevant to well-being is 
made. Both are subjective, and both may be regarded as patient reported outcomes (PRO) 
defined by the U.S. Food and Drug Administration (FDA) as “any report coming directly 
from patients about a health condition and its treatment” (154).  
 
Pain 
Inherent limitations considered; a main contribution of the current study is the finding that 
pain was musculoskeletal and related to CP across all GMFCS levels. A journal commentary 
on paper I (155) call attention to several papers on pain in paediatric CP from 1965 until today 
and states that most pain related to CP can be treated effectively with well-tuned 
multidisciplinary care; thus suggesting that pain is recognised in research, but still under-
treated in medical practice. As discussed in the Introduction section, most reports on pain in 
paediatric CP do not review the origin of pain. Claiming that pain is related to CP and of 
musculoskeletal origin adds weight to the obligation of health care measures to relieve pain 
and forwards a direction of such measures. 
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The assessment of pain was piloted in the gait laboratory for a year before study start. The aim 
was to record all kinds of recurrent pain, but we soon experienced that few children reported 
headaches or stomach pain. This made us refine the questions and present a body outline for 
the recording of pain localisation two times - first the interviewer recorded pain localisations 
during the interview, then children and parents recorded localisations while completing 
questionnaires in private. In general, more localisations were recorded by the children and 
parents themselves, but still headache and stomach pain were recorded very seldom. This is 
not in accordance with a Swedish study of children in the general population, studying 
recurrent pain in the head, stomach or back (156). In this study, two thirds of the children 
reported at least monthly pain, one third reported weekly pain and 4 of 10 experienced pains 
from multiple locations. One might speculate that the experience of recurrent pain related to a 
specific health condition influence on reports of other kinds of pain, but I have not been able 
to find relevant literature on this topic.  
 
Paper IV contributes with an example of medical treatment of RMP in multidisciplinary care 
and discusses how to tune the care after pain relief. Later reports on CITB do not address 
musculoskeletal pain in particular, but a recent retrospective study of 25 non-walking adults 
with CP also concludes that CITB relieved pain (157). A prospective study of children with 
severe spastic CP compared children receiving CITB to children waiting for CITB (158). 
Changes on the ICF level of body function (reduced spasticity and increased joint range of 
movement) after initiation of CITB treatment occurred together with an improvement of QoL 
in terms of comfort and ease of care. Changes in participation as expressed by PEDI total 
summary scores could not be demonstrated. In a randomised controlled study of non-walking 
children with bilateral spastic CP, children that received CITB obtained pain relief and mental 
health improvement as assessed by the CHQ, but PEDI total summary scores did not differ in 
the two groups (159). A follow-up study confirmed that pain relief and improved mental 
health persisted after 12 months, and also that PEDI total summary scores did not change 
(160). As only PEDI total summary scores are given in these studies, a comparison with the 
changes on the PEDI domain of social function in the present study is not applicable. Thus, 
the finding of pain relief in the present study is supported by later studies, while the finding of 
improved participation still has to be confirmed.  
 
Recommended primary treatment goals for CITB are reduction in pain, reduced caregiver 
burden, improvements in sleep, sitting, QoL and activities of daily living (161); i.e. primarily 
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PROs. CITB is expensive, the carrying-out relies on considerable efforts from both families 
and health care providers and the treatment has a certain frequency of potential serious 
complications. Still, CITB is recommended in the treatment of severe spasticity in children 
with CP at GMFCS levels IV-V; despite lack of evidence that CITB could affect disability, 
function or QoL (162). However, caregivers’ satisfaction with CITB is reported to be high 
(157;160;163). A reason why CITB has remained a treatment option in this selected patient 
group might be that doctors do listen to patients and their caregivers.  
 
In the ICD-10 (13), pain is not assigned to CP. Neither can pain be recognised in Chapter XIII 
“Diseases of the musculoskeletal system and connective tissue” (M00-M99). In the ICF (12), 
pain is coded on the list of body functions & structure (Chapter b2 Sensory Functions and 
Pain), but no specifications in the direction of tissue involved or localisation can be made in 
accordance with the ICF shifting the focus from cause to impact of disease. This indicates that 
the ICF, but not the ICD-10 gives a frame of reference for understanding pain in CP.  
 
Mental health problems 
Mental health problems is another known consequence of the underlying brain lesion in CP 
that tend to go under-recognised and therefore under-treated (62;164;165). The finding in the 
present study (paper II) of mothers reporting more child mental health problems than parents 
of typically developing youth contributes with a reminder of this health care challenge. From 
a research point of view, the finding is reassuring because it corresponds to previous findings, 
thereby indicating representativeness of the study population. The self-report on mental health 
represents the novel contribution of the study together with the report that RMP and mental 
health problems are associated according to the children. Corresponding to the latter, parents 
in the SPARCLE –study reported that pain was associated with more mental health problems 
(66). In contrast, in the present study, a potential association between RMP and maternal 
reported SDQ total difficulties scores did not obtain statistical significance. This may 
represent a type II error in the present study (less powered) or reflect real differences because 
of dissimilarities in study populations (current study population not representative for the total 
CP population), differences in the definition of pain (RMP versus pain in general) or different 
proxy-reporters (mothers versus parents).  
 
Although the literature on self-reported mental health in children with chronic health 
conditions seems very scarce, reports on children with chronic health-conditions not involving 
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the central nervous system indicates that parents tend to overestimate mental health problems  
and in particular internalising  problems (166;167).  The SDQ website (153) gives normative 
data from eight countries, but self-reported data only from United Kingdom and Australia. In 
both countries, self-reported SDQ total difficulties scores are higher than parent-reported 
(UK: 10.3 SD 5.2 versus 8.4 SD 5.8 and Australia: 9.0 SD 5.6 versus 8.2 SD 6.1). Given the 
overlap between mental health and psychosocial HRQL/QoL issues, a reasonable hypothesis 
is that a similar pattern as in HRQL/QoL reports is about to emerge; that means children with 
health conditions report less problems than parents do while children without health 
conditions report more problems.  
 
Mental health problems are covered in Chapter V “Mental and behavioural disorders” (F00-
F99) in the ICD-10 and are, like pain, coded on the list of body functions & structure in the 
ICF (Chapter b1 “Mental Functions”). Where the approach of the ICD-10 is the categorical 
depending on reliable diagnostics of mental health disorder, the ICF offers a dimensional 
approach being able to encompass all levels and combinations of mental health problems. 
Thus, in the understanding of mental health problems in CP, the ICD-10 and the ICF are 
complementary, as stated on a general base in the background section.  
 
HRQL 
Proceeding to potential impact of disease, the framing is extended from impact on function in 
paper I to impact on HRQL in paper II; the HRQL construct thought to be closer to well-being 
than function. The distribution of HRQL scores in the present study contributes to the body of 
knowledge from similar studies. Mothers’ report being influenced by own mental health and 
underestimating child HRQL is in accordance with other studies (65;85;86;168), thereby 
indicating representativeness of the study population. A more original contribution is the 
observation that children with RMP reported that pain was less severe, but influenced more on 
HRQL than mothers believed. The children in the current study join Swedish children from 
the general population in stating that recurrent pain highly influence HRQL as assessed with 
PedsQL 4.0 generic score scale (156). The last contribution is national with a comparison of 
the HRQL of children with CP able to self-report and the general Norwegian population.  
 
The HRQL concept can be retrieved neither in the ICD-10 nor in the ICF. It is argued that the 
ICF recognises a person’s own view of his health, but concerns have also been raised claiming 
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that the ICF overlooks the subjective experience of the individual and because the notion of 
client-centeredness is not build into the framework (14). According to the ICF manual, the 
concept of personal  factors  include “gender, age, coping styles, social background, 
education, profession, past and current experience, overall behaviour pattern, character and 
other factors that influence how disability is experienced by the individual ”(12). Thus, a 
reasonable statement is that the HRQL concept overlaps with the concept of personal 
contextual factors in the ICF, indicating that the ICF incorporates some aspects of well-being 
related to health. It has also been argued that the ICF recognises the QoL concept, including 
the persons’ view of his own participation (1). Again with reference to the ICF personal 
contextual factors, it may as well be argued that the ICF incorporates elements of well-being 
that applies to all children.  
 
Participation 
In paper III and IV the framing of impact of disease is that of participation – a key concept or 
the key concept of the ICF. Study A contributes with a description of scores among children 
with CP on the full LIFE-H tool and an assessment of participation taking both pain and 
mental health problems into account. The results indicate that RMP and mental health 
problems are both associated with reduced participation and that parents’ satisfaction with 
child participation is influenced by their own well-being (paper III). Study B gives an 
indication that effective pain treatment may be associated with increased participation in a 
selected patient group (paper IV). On pain, the findings adds to those of the SPARCLE-study 
(80) and contributes to an increasing body of knowledge of a sequence “CP
reduced participation.” In contrast, I have not been able to identify other reports on relations 
between child mental health and participation.  
 
A weakness of the study is that only proxy-reported LIFE-H scores are available. The LIFE-H 
holds elements of both objectivity (which tasks are performed and what assistance is needed) 
and subjectivity (perceived difficulty with performing a task and satisfaction). The LIFE-H 
domains follow the ICF closely and the questions correspond to the ICF performance qualifier 
that measures the difficulty the respondent is experiencing in doing things. Separate formats 
for self- and parent-report are not developed, and in general I am not aware of studies that 
compare self-reported and parent-reported participation. Given that parents of children with 
health conditions tend to underestimate child HRQL/QoL (85) and the similarities between 
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some HRQL/QoL and participation items, one might hypothesise that parents of children with 
CP may be prone to underestimating child participation as well.  
 
A question of general interest is to which extent parental satisfaction is relevant in the 
assessment of child participation. The notion of participation as an objective outcome (87) 
does certainly not support neither the relevance of satisfaction (whether parent- or self-
reported) nor incorporating the aspect of perceived difficulty in performing a task. 
Incorporating aspects such as intensity (107), child independence and child enjoyment (106) 
are in accordance with the definition of participation requiring “involvement in life 
situations,” but still challenges participation as an objective outcome. If participation is 
regarded an observable rather than an objective outcome, the latter challenges are overcome to 
a certain extent. On the other hand, both the “objective” and the “observable” view promote 
the inclusion of aspects such as frequency and diversity of participation. Thus, regarding 
participation as an observable, but not objective outcome might be a more fruitful approach 
along the road to both clarifying the interface between activity and participation and 
operationalising the participation concept.  
 
One may also be allowed to question how participation is useful in understanding patient 
well-being. As discussed in the Introduction section, measures that claim to capture 
participation differ in their approach to the subjective element (108;109). The ICF itself is 
clearer than the LIFE-H instructions in telling that the Performance qualifier measures the 
difficulty the respondent is experiencing in doing things, assuming that they want to do them. 
In accordance with this, the CP consensus group promotes that “accompanying impairments 
should be classified as present or absent, and if present, the extent to which they interfere with 
the individuals’ ability to function or participate in desired activities should be described” (1). 
Thus, in participation, the gap between actual and desired performance may be a key factor, 
like the gap between experiences and expectations is said to be a key factor in the HRQL/QoL 
concept (84). At present, HRQL and QoL both seem to be closer to well-being than 
participation and the relations between HRQL/QoL and the ICF still need to be clarified. One 
recommendation is that of including an individual’s satisfaction with various aspects of life 
and overall life quality as codes in the personal factors component of both the ICF and ICF-
CY, when codes for that component are developed (169).   
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Family factors 
The findings that parental mental health was associated with parental view on child mental 
health, child HRQL and satisfaction with child participation were not unexpected. Several 
studies have reported that child well-being, parental well-being and family function are 
related. Examples are studies from other health conditions than CP reporting that in general, 
poorer physical child health is associated with more problematic family situation (170-172), a 
study from Northern Russia including adolescents with diabetes, asthma and epilepsy finding 
that longer disease duration contributed to family dysfunction (173), and a recent Canadian 
study of school-aged children with CP reporting that parents are likely to experience high 
stress, increased time constraints and financial and psychological burden (174). In general, the 
literature on the associations between child and parental well-being seems to have obtained 
sufficient robustness to claim that parental stress, parental mental health or a similar construct 
should be included in most studies on child well-being as assessed by parents.  
 
A shift from the family perspective to the ICF reference frame promotes a linking of family 
related variables to the ICF as contextual factors. The ICF contextual factors allow for the 
discussion of and evidence-gathering about how impact of disease may be modified by 
facilitators or barriers. Personal contextual factors are so far not further operationalised, while 
a list of environmental factors are provided. In the present study, the factors “Living together 
with both parents”, “Mother’s education” and “Parental mental health” have relevance for 
both “Support and relationships by immediate family members” and “Attitudes by immediate 
family members” on the ICF list of contextual factors, indicating that the ICF reference frame 
has the potential to take care of the family perspective and facilitate the inclusion of parental 
mental health (or similar constructs). This is also in accordance with the bio-psycho-social 
health approach being incorporated in the ICF.   
  
Framing of the study 
Given that participation may be too demanding to assess in an unambiguous fashion, the ICF 
still offers a reference frame useful to obtain a comprehensive understanding of a child’s 
status. The current study contributes with an example from paediatric neurodisability of how 
outcomes  described by professionals (spasticity and joint range of movement), 
comprehensive PROs (HRQL and participation) and a variety of explanatory variables all may 
be framed by the ICF together with the health condition in question. In table 3, variables are 
sorted according to a tentative placement within ICF domains. The relations of GMFCS, 
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PedsQL, LIFE-H and PEDI to the ICF are discussed in the text. Elements of socioeconomic 
state are contextual factors that may be both environmental and personal as socioeconomic 
state may impact personal views. The same argument might be presented for family 
characteristics and probably also for parental mental health and parental satisfaction with 
participation. For the placement of variables such as spasticity, age and sex, the ICF is self-
instructing. 
 
Table 3.  Variables sorted according to a tentative placement across ICF domains.*  
Roman numerals refer to paper. 
 
Impairments Limitations and restrictions Contextual factors 
(barriers or facilitators) 
Body 
structures 
Body functions Activity Participation Personal factors Environmental 
factors  
x RMP 
Clinical judgement (I-IV) 
Gross motor 
capacity 
GMFM-66 (IV) 
Ambulation 
GMFCS (I-IV) 
Age and sex  
(I-III) 
Place of living 
 (I-III)  
 
x Pain localisation 
Body map (I) 
Pain impact  
NRS, Rating (I, IV) 
x Social 
background (I-III) 
Family income 
 (I-III) 
x Pain  
CHQ, FPS-R, Rating 
(I,II,IV) 
Self-care 
PEDI (IV) 
Self-care 
PEDI (IV) 
HRQL (II) Mother’s 
education  
Years (I-III) 
x Global intellectual  
Function, indicator (III) 
Mobility 
PEDI  (IV) 
Mobility 
PEDI (IV) 
x Family 
characteristics 
 (I-III) 
x Mental health  
SDQ  (II, III) 
Social function 
PEDI  (IV) 
Social function 
PEDI (IV) 
x Parental mental 
health GHQ 
 (II, III) 
x Joint range of  
movement (IV) 
x Global 
participation 
LIFE-H (III) 
x Parental 
satisfaction with 
Global 
participation 
LIFE-H (III) 
x Spasticity  
Mod. Ashworth (IV) 
x Accomplishment 
of daily activities 
LIFE-H (III) 
 
x Parental 
satisfaction with 
Accomplishment 
of daily activities 
LIFE-H (III) 
 
x x x Accomplishment 
of social roles  
LIFE-H (III) 
x Parental 
satisfaction with 
Accomplishment 
of social roles  
LIFE-H (III) 
* Limitations and alternative placements are discussed in the “Discussion” section of the text. 
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6.2 Methodological issues 
6.2.1 Study design and stability of findings.  
Due to the cross-sectional design of study A, the stability of findings can be questioned. In 
general, a potential lack of stability may relate to the measures or to the states being measured. 
The reliability of the Norwegian versions of PedsQL and CHQ is tested  and found satisfactory 
(116;135). The reliability of the Norwegian version of SDQ is not formally tested, but the SDQ is 
widely used both for research and clinical purposes (130;132;175;176) and the distribution of 
SDQ scores in typically developing youths are found to be very similar across the Nordic 
countries (129). The Norwegian version of LIFE-H has been translated according to international 
guidelines and cultural validity and reliability studies (content- and construct validity and test-
retest reliability) have been performed, but not yet published (Reidun Jahnsen, personal 
communication). Concerning the states being measured, pain is a fluctuating phenomenon. The 
time span asked for by the instruments used correspond to a certain extent; the CHQ asks for 
“last 4 weeks”, the PedsQL asks for “last month” while the SDQ asks for “last six months.” We 
chose the shortest time-span for the impact and localisation of pain reported on the BPI and the 
maximum pain intensity reported by the children on the FPS-R to ensure that the time-span of 
last four weeks was covered by all instruments. During the interviews, some children gave the 
impression of uncertainty of a time span of four weeks or one month, but still seemed confident 
with the term recurrent pain. This may indicate that they recognised a state of recurrent pain as 
something stable enough to help them answer the other questions on pain. Another major 
limitation of cross-sectional observational studies is the limited possibility to conclude on 
causality because all information is collected at the same time (177).  
 
The longitudinal design of study B is the stronger regarded the stability of findings. Spasticity 
defined as “velocity dependent increase in stretch reflexes” should be a precise sign (178) 
reflecting a stable state, but the MAS also reflects muscle tone that may fluctuate in a child. The 
stability of MAS should therefore be questioned.      
   
6.2.2 Representativeness of the study population  
In study A, a major weakness is that participants are not selected randomly from a population-
based register. Unfortunately, recruitment from the Cerebral Palsy Register in Norway was 
not an option, as this register only covers birth cohorts from 1996 and younger. Looking at the 
representativeness of the population-based group, an estimated prevalence of 2.1 per 1000 live 
births 1996 -1998 in Norway (5) indicate 131 potential participants born in the area and a 
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capture rate of 57% with no correction for migration. An estimated CP point-prevalence of 2.4 
per 1000 inhabitants born 1992-1993  in Sweden (179) indicate 164 potential participants 
living in the geographic area, giving a capture rate of 47 %. Most participants (76 %) were 
recruited from the habilitation units. There is one habilitation unit in each county having the 
responsibility for the county’s inhabitants. The number of invitation letters sent from each unit 
was compared to the estimated number of potential participants from the corresponding 
county. The results varied from 41 -110 %. Inadequate patient registers in the habilitation 
units are therefore considered a main reason for the somewhat disappointing enrolment in the 
study, but give no concerns in the direction of selection bias beyond the general concern that 
children with the most minor impairments may not be registered. We regard the distribution 
of CP types and GMFCS levels as comparable to that found in population studies (5;42-44), 
indicating that the group may be non-biased with respect to these aspects. Still, a volunteer 
bias (177) may be present, as we do not know whether the volunteers that participated in the 
study differ from those who did not. Proceeding to the hospital-based group, obviously, non-
walkers are not represented. We also expected a bias in the direction of children with minor 
motor impairment not being referred. Somewhat reassuring, the gross motor impairment was 
classified as GMFCS I in 32%.  
 
In study B, the study population is regarded representative for children found eligible for 
CITB at the time present as the selection of patients followed recommendations in a 
consensus document from 2009 (161). Further, the majority of patients being non-walkers 
(94%) are in accordance with both previous (180;181) and more recent studies (157;182). 
Rikshospitalet was the first Norwegian hospital to offer CITB treatment to children, and 
started to do so in 1998. The number of patients treated was increasing from 1998 and reached 
a plateau in 2003, indicating that a steady state between referrals and treatment was obtained. 
Rikshospitalet is still the only hospital in the South-East part of Norway offering CITB. 
Professional communication between actual hospitals is good and patients living in South-
East Norway are not expected to be referred to other hospitals. Neither are hospitals in regions 
not offering CITB expected to refer to other hospitals than Rikshospitalet. As all medical 
pump implants are registered at the time of implantation, we know that no patients were lost 
to follow-up.  
 
Both gait analyses and CITB were performed within the public health care system; thus major 
selection biases on socioeconomic factors in the two hospital-based groups are not expected.   
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6.2.3 Measures – validity and overlap 
Pain 
The PedsQL include one question on pain on the domain of physical functioning. Only pain 
frequency is assessed, which was regarded insufficient in the present study. Still, one should 
be aware that pain influence on PedsQL total score. Study B relies on parents’ observations of 
pain behaviour that are not standardised. A validated observational instrument  such as the 
Face Legs Activity Cry Consolability Scale (FLACC) (82) or a questionnaire with known 
psychometric properties might represent more reliable options. 
 
Mental health and HRQL 
The validity of the SDQ is questioned in children with severe motor and intellectual 
impairment (66), while the validity as a screening instrument for mental health problems in 
children without intellectual or physical disabilities seems well established (128;130-132). 
Thus, in the present study, the assessment of mental health in children that were able to self-
report is probably more valid than the assessment of children not able to self-report.  
 
The items in the PedsQL focus on functioning and what the child can do, which obviously 
may be affected by the motor impairment in CP. This is relevant both for the physical domain 
and for some questions on the psychosocial domains, exemplified by the item “it is hard for 
me to keep up with my peers” on the domain of social function. Further, even if the PedsQL 
demonstrates some general challenges of the HRQL construct as pointed out in the 
Background section, PedsQL might still be regarded a relevant measure in CP because motor 
function is an important part of the CP health condition. A CP module of PedsQL is 
developed with more items reflecting the motor impairment on all domains in addition to four 
items on Pain and Hurt on the physical domain (134). In longitudinal studies or in studies not 
intended to compare scores with typically developing youth or across health conditions, the 
CP module is probably the better choice because of greater sensitivity than the generic core 
set alone (134). In general, despite the conceptual challenges discussed in the Background 
section, HRQL might be regarded a more relevant outcome measure than QoL in 
(re)habilitation medicine; simply because health issues and impact of health conditions are the 
primary focus of health care services.  
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Similarities between the items of SDQ and the PedsQL psychosocial domains are reflected in 
observations of correlation (167;183), but to my knowledge, results of content analyses 
comparing the two constructs has not been published. Still, PedsQL is reported to be strongly 
related to behaviour assessed with Child Behavior Checklist (CBCL) (184).  
 
Participation 
As discussed previously, the LIFE-H holds elements of both objectivity and subjectivity and 
separate formats for self- and proxy-report are not developed. Thus, the process of validation 
seems not yet to be completed even if the content validity is regarded as satisfactory (105). On 
the other hand, the instruction is clear in asking for how the person usually accomplishes a life 
habit. The domains follow the ICF closely and the questions correspond to the ICF 
performance qualifier that measures the difficulty the respondent is experiencing in doing 
things in daily life. The PEDI is clearer on who is the reporter than LIFE-H in asking for the 
observations of a primary caregiver. It is also clear in using the interview format, where 
LIFE-H may be administered as a questionnaire or given as an interview. The Functional 
Skills Scale of the PEDI asks about what a child can do in his/hers daily environment, by 
some authors labelled capability (138). Still, the scoring instruction tells to give a score of one 
only if the child usually performs a task, indicating that PEDI captures performance as 
necessary for being a measure of participation. In accordance with this, the conceptual basis 
of both PEDI and LIFE-H is found to match the ICF concepts of activity, participation and 
environmental factors (adaptations and devices) to a large extent (138). Also the PedsQL is 
reported both to cover the ICF substantially (185) and to be strongly related to function 
assessed with PEDI in 2-3 years olds (184). In general, the reasons given for the suggestion to 
incorporate  QoL and participation in the classification of CP (1) might as well be applied for 
other complex, chronic paediatric health conditions. Examples are rheumatoid arthritis, cancer 
survivorship, post organ transplants and severe congenital heart defects.   
 
Motor function 
In study B changes in motor function was assessed both with PEDI and GMFM. The two 
measures comprise different approaches, and are complementary rather than overlapping. 
Reliability tests of the Norwegian version of GMFM are not published internationally, but the 
GMFM is widely used and is still regarded useful by the Norwegian National Cerebral Palsy 
Follow-up program (186). The issue of changes in motor function due to natural child 
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development is generic and is incorporated in the validation process of all measures that intend to 
assess paediatric function.      
  
Spasticity 
The MAS assesses resistance to rapid, passive movements. Even if the inter-rater reliability in 
measuring muscle tone is regarded acceptable (125;126), the validity of MAS in the 
assessment of spasticity has been profoundly questioned (187;188). The importance of 
spasticity for functional outcome in children with CP is also doubtful (189), indicating that the 
MAS outcome does not contribute substantially to the validity of study B.  
 
6.3 Implications 
6.3.1 Clinical implications 
The findings in the current study support that a bio-psycho-social approach is 
relevant in the health care for children and adolescents with CP. Monitoring of pain, 
mental health and family wellbeing should be part of the clinical follow-up across the 
whole range of motor impairment. The child’s own perspectives should be recorded 
when possible in addition to that of the parents, as children and parents tend to have 
different views on impact of pain, on mental health and on HRQL. Systematic 
assessment of HRQL may serve as a tool to broaden the scope of the consultation in 
(re)habilitation towards both pain and psychosocial issues. Close cooperation 
between (re)habilitation and child psychiatry can assist in making proper psychiatric 
diagnoses, tailor individual measures to relieve mental health problems and take care 
of the family perspective. The ICF classifications might be helpful in describing the 
child’s condition precisely in a shared language, but participation as a comprehensive 
PRO at present seems to be less useful for clinical purposes because of its limited 
operationalisation.    
 
6.3.2 Research implications 
The main limitations of the present study (small numbers, cross-sectional design of 
study A) invite to conclude that more powered or better designed studies are needed 
on the specific topics addressed. I find it more fruitful to draw attention to the 
ongoing discussion on how to develop the evidence base in paediatric neurodisability 
in general. An editorial in a leading journal on the field states that “the criterion of a 
randomised controlled study may not be able to address the big questions in 
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neurodisability (190). Further, the need for multicenter studies and long-term-follow-
up is widely agreed upon (191;192). Bearing this in mind while returning to the 
topics of the current study, the course of pain and mental health problems from 
childhood through the transition into adult life need to be explored across all GMFCS 
levels, as do the impact of interventions aimed to prevent or relieve pain and/or 
mental health problems. Studies on children’s narratives on pain experiences have 
the potential to give new insights into the pain problem. On self-reported mental 
health, more powered studies are warranted; both on mental health in general and in 
more detail on the different elements of mental health.  
 
As previously discussed, the concept of participation needs to be further clarified and 
operationalised both in general and in relation to children with CP. In addition, much is yet to 
be explored about how the ICF-CY relates to other measurement tools useful in paediatric 
neurodisability research. In CP, the impact of mental health problems on participation 
deserves further study, in addition to research on resilience factors or which factors promote 
activity and participation. An example of the latter is a Canadian study reporting that in 
school-aged children, high motivation in mastering challenging tasks was associated with 
fewer activity limitations and behavioural problems and reduced family burden (193). A path 
of potential interest would be to include resilience factors in studies of the impact of 
interventions such as intensive motor training and orthopaedic surgery that tend to decrease 
participation and probably also QoL/HRQL in the short run even if the aim of the 
interventions in the long run are said to be increased QoL/HRQL and participation. In general, 
a bio-psycho-social approach will be needed in most studies to catch the comprehensiveness 
of the CP disorder.       
 
6.3.3 Concluding remark 
The WHO defines health as “a state of complete physical, mental and social well being and 
not merely the absence of disease or infirmity”(194). In CP, a basic element in the 
understanding of the medical condition is that a state of absence is unattainable with today’s 
knowledge. The ICF is mandatory in paying respect to the impact of disease and offers a 
comprehensiveness that in my opinion makes it the reference frame of highest relevance in 
both clinical practice and research concerning chronic conditions. The ICF also offers the 
common language that is necessary to incorporate the patient’s own views of what concerns 
disease. Ancient Rufus prepared the field. 
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Erratum:  
In Paper I, the first word in the main document should be “Pain”, not “Musculoskeletal pain”.   
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